A delegation of GenoMed4All partners attended the EBMT 51st Annual Meeting in Florence from March 30 to April 2. Hosted at The Fortezza Da Basso Congress Venue, this hybrid event connects more than 5,500 healthcare professionals from all over the world with cutting-edge scientific content related to transplantation and cellular therapy.
GenoMed4All was featured in a session focusing on “Artificial Intelligence and Machine Learning: AI for next-generation clinical trials in hematology“, co-chaired by Matteo Della Porta (Humanitas Research Hospital), with talks on:
- ‘Generative and distributed AI to improve access and use of real-world data to accelerate clinical research in hematology‘, by our project coordinator, Federico Alvarez (Universidad Politécnica de Madrid)
- ‘A legal perspective from AI ACT on the use of generative AI in medicine‘, from our colleague Nathan Lea (The European Institute for Innovation Through Health Data)
